TARS
Tarsus Pharmaceuticals Inc
$61.95
-1.05% ($0.66)
Volume
267,320
52W High
$85.25
52W Low
$38.51
Market Cap
$2.81B
Next Earnings Report
Last Reported
May 12, 2026 Missed
Actual: -$0.16
vs. Consensus: -$0.03
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 12, 2026
1-Day:
+8.07%
Q1 2026
May 6, 2026
1-Day:
-1.24%
5-Day:
-7.89%
Q1 2026
Apr 30, 2026
1-Day:
+0.02%
5-Day:
+2.25%
Q4 2025
Mar 16, 2026
1-Day:
+1.29%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $151.7M | +128.4% | 92.8% | -5.3% | -$8.4M |
| Q3'25 | $118.7M | +146.7% | 79.3% | -12.2% | -$12.6M |
| Q2'25 | $102.7M | +151.5% | 93.9% | -21.6% | -$20.3M |
| Q1'25 | $78.3M | +183.7% | 93.4% | -33.6% | -$25.1M |
| Q4'24 | $66.4M | +407.9% | 92.6% | -36.8% | -$23.1M |
| Q3'24 | $48.1M | +2,471.8% | 93.3% | -52.3% | -$23.4M |
| Q2'24 | $40.8M | +167.2% | 92.6% | -81.6% | -$33.3M |
| Q1'24 | $27.6M | +1,004.6% | 94.0% | -136.5% | -$35.7M |
Company Information
Symbol
TARS
Company
Tarsus Pharmaceuticals Inc
Market Cap
$2.81B